摘要
目的从天然药物中筛选β淀粉样肽聚集抑制剂。方法建立β淀粉样肽聚集抑制剂筛选模型的酶联免疫吸附测定(ELISA)检测方法,同时使用刚果红结合试验和硫磺素T分析试验对部分中草药提取物进行活性筛选,并对活性部位进行分离跟踪。结果灯盏细辛乙醇提取物显示β淀粉样肽聚集抑制活性,经跟踪分离测定发现其所合成分木栓酮为抑制作用活性成分。结论成功地建立了一种基于ELISA原理的β淀粉样肽聚集抑制剂筛选模型;用该模型筛选到灯盏细辛提取物及其所含化学成分木栓酮具有抑制β淀粉样肽体外聚集的活性。
Abstract
OBJECTIVE To screen the inhibitors of β amyloid aggregation from natural preducts. METHODS A screening assay was established based on ELISA theory to screen the inhibitors of β amyloid aggregation.The inhibition was determined by congo red binding assay and thiotlavin T binding assay.Some herbs were screened. The active compounds were isolated and tracing detected. RESULTS The ethanol extract of Erigeron breviscapine(vant) was found to be active, the active component was isolated and elucidated as friedelin. CONCLUSION A screen assay is successfully established based on ELISA theory for screening the inhibitors of the β amyloid aggregation in vitro. Ffiedelin prevents the aggregation of synthetic β amyloid in vitro.
关键词
β淀粉样肽 /
抑制 /
聚集 /
木栓酮 /
灯盏细辛
{{custom_keyword}} /
Key words
β amyloid /
inhibition /
aggregation /
friedelin /
Erigeron breviscapine
{{custom_keyword}} /
赵彬;杨红军;赵晶.
β淀粉样肽聚集抑制剂体外筛选模型的建立及木栓酮抑制活性研究[J]. 中国药学杂志, 2005, 39(19): 1474-1476
ZHO in;YNG Hong-Jun;ZHO Jing.
Development of an assay for screening β amyloid aggregation inhibitors in vitro and study on inhibitive activity of friedelin[J]. Chinese Pharmaceutical Journal, 2005, 39(19): 1474-1476
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1］Tomiyama T， Asano S， Suwa Y，et al. Rifampicin prevents the aggregation and neurotoxicity of amyloid β protein in vitro[J］.Biochem Biophy Res Commun，1994，204(1)：76.
[2］Nakagami Y， Nishimura S， Murasugi T， et al. A novel b-sheet breaker， RS-0406， reverses amyloid β-induced cytotoxicity and impairment of long-term potentiation in vitro[J］.Br J Pharmacol，2002，137；676：682.
[3］Stephen JW， MacKenzie L， Maleeff B，et al.Selective Inhibition of Ab Fibril Formation[J］. J Biol Chem，1996，271(8)：4086.
[4］Hilal AL， Dean MH， Balakhaneh D，et al. New class of inhibitors of amyloid-β fibril formation. Implication for the mechanism of pathogenesis in Alzheimer’s disease[J］.J Biol Chem，2002， 277(45)：42881.
[5］Geerts H. NC-531 (Neurochem)[J］.Curr Opin Investig Drugs，2004，5(1)：95.
[6］张卫东，陈万生，孔德云，等.中药灯盏细辛化学成分的研究(I)[J］.第二军医大学学报，2000，21(2)：143.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
云南省自然科学基金(2002C0023Q)
{{custom_fund}}
